Verastem, Inc. (VSTM) Deep Dive Video

Name: Verastem, Inc. (VSTM) Deep Dive Video | Flash
Uploaded: 2026-06-20T01:13:47.738Z
Description: Verastem is a highly asymmetric oncology bet: newly commercial in rare ovarian cancer, potentially transformative in KRAS G12D tumors, but exposed to binary trial risk and dilution.

Summary

Verastem is a highly asymmetric oncology bet: newly commercial in rare ovarian cancer, potentially transformative in KRAS G12D tumors, but exposed to binary trial risk and dilution.

View VSTM stock page · Read the VSTM research report

Loading the video player…

Loading Flash…